TABLE 2.

Subject-matched characteristics and fatty acid composition (% main classes) of fasting plasma NEFA and phosphatidyl choline according to genotype and gender

	Females (mean ± SEM)		Males (mean ± SEM)
	Asp289 (n = 14)	Glu298 (n = 15)	Asp289 (n = 15)	Glu298 (n = 15)	P between Genotypes	P between Genders
Age (y)	27.6 ± 3.07	27.1 ± 2.98	28.5 ± 3.54	28.4 ± 3.46	0.995	0.734
BMI (kg/m2)	22.4 ± 0.2	22.5 ± 0.2	24.1 ± 0.2	23.8 ± 0.2	0.893	0.069
Blood pressure
Systolic (mmHg)	118.6 ± 0.5	118.2 ± 0.5	129.7 ± 0.5	127.0 ± 0.6	0.514	<0.001
Diastolic (mmHg)	77.2 ± 0.6	76.3 ± 0.6	76.1 ± 0.6	75.6 ± 0.7	0.746	0.699
Baseline plasma NEFA composition
SFA (%)	38.5 ± 0.8	39.3 ± 1.1	38.6 ± 0.8	37.9 ± 0.8	0.983	0.438
MUFA (%)	37.1 ± 1.4	35.3 ± 2.5	37.3 ± 1.2	38.2 ± 0.8	0.783	0.336
n-6 PUFA (%)	12.9 ± 0.5	13.9 ± 0.8	12.2 ± 0.4**	14.0 ± 0.5	0.019	0.681
LC n-3 PUFA (%)	1.4 ± 0.2	1.5 ± 0.2	1.6 ± 0.2	1.5 ± 0.2	0.945	0.810
Baseline plasma PC composition
SFA (%)	40.8 ± 0.4	39.9 ± 0.4	39.8 ± 0.5	39.0 ± 0.6	0.080	0.048
MUFA (%)	10.7 ± 0.5	9.7 ± 0.3	35.3 ± 0.4	10.3 ± 0.3	0.323	0.790
n-6 PUFA (%)	30.0 ± 0.5	28.8 ± 0.4	29.1 ± 0.5	28.3 ± 0.5	0.316	0.693
LC n-3 PUFA (%)	3.9 ± 0.4	4.3 ± 0.3	4.5 ± 0.3	4.1 ± 0.2	0.966	0.623

Statistical significance of difference between genotypes within a gender: **P ≤ 0.01. Bold text indicates significant P-values.